NCT00280462View on ClinicalTrials.gov

Choroidal Blood Flow Regulation During Isometric Exercise: Effects of Ca2+-Channel Blockade

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
Ocular PhysiologyRegional Blood Flow
Interventions
DRUG

Nifedipine (drug)

Nifedipine (Adalat®, Bayer, Leverkusen, Germany) dose: 15µg/kg bolus infusion over 5 minutes; 0.2 µg/(kg.min) maintenance dose infusion period 25 minutes

DRUG

L-Arginin (drug)

L-Arginin (Clinalfa AG, Läufelfingen, Switzerland) 30% sodium chlorid solution, dose: 1g/min over 30 minutes

DRUG

Placebo

Placebo

Trial Locations (1)

1090

Department of Clinical Pharmacology, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT00280462 - Choroidal Blood Flow Regulation During Isometric Exercise: Effects of Ca2+-Channel Blockade | Biotech Hunter | Biotech Hunter